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PENILAIAN TENTANG PENGETAHUAN DAN KEPATUHAN TERHADAP 
PENGUBATAN: SUATU KAJIAN METODOLOGI BERCAMPUR DALAM 
KALANGAN PESAKIT DENGAN  DIABETES MELLITUS JENIS 2 DI 
PULAU PINANG 
 
ABSTRAK 
Prevalens diabetes mellitus telah meningkat begitu ketara dalam kalangan populasi 
Malaysia sejak dekad yang lalu.  Tambahan pula, pengurusan diabetes yang 
berkaitan morbiditi sentiasa berdepan dengan cabaran oleh penyedia penjagaan 
kesihatan.  Dalam usaha menyediakan pengurusan penyakit yang optimum, terdapat 
keperluan bagi mendedahkan pesakit diabetis terhadap pendekatan pengurusan diri 
diabetes.  Walaupun langkah perlu telah diambil untuk meningkatkan kawalan 
glisemik dalam kalangan pesakit diabetes di Malaysia, namun hasilnya masih belum 
mencukupi. Kepatuhan terhadap pengubatan, tahap pengetahuan pesakit serta 
persepsi mereka tentang diabetes masih belum didokumenkan sebaiknya di negara-
negara sedang membangun. Kebanyakan usaha intervensi untuk meningkatkan 
kepatuhan terhadap pengubatan dan amalan pengurusan-diri diserapkan dalam 
kandungan pendidikan.  Intervensi ini berdasarkan andaian bahawa pengetahuan 
tentang diabetes mungkin memberi kesan terhadap kesedaran pesakit serta 
mempengaruhi kepatuhan mereka terhadap regimen rawatan. Dalam konteks ini, 
kajian yang dijalankan di Malaysia tentang diabetes dan kepatuhan terhadap 
pengubatan adalah agak terbatas.  Di samping itu, pengalaman dan persepsi pesakit 
diabetes tentang penyakit dan pengubatannya tidak banyak ditonjolkan. 
xx 
 
Dalam usaha meneroka serta memahami kepercayaan dan pengalaman pesakit, 
kaedah penyelidikan kualitatif dikira amat berguna. Malahan, ia dapat menjelaskan 
senario ini dengan lengkap, yang tidak mampu dijelaskan melalui penyelidikan 
kuantitatif.  Justeru, metodologi rentas campuran (kajian kualitatif dan kuantitatif) ini 
secara prinsipnya bertujuan menilai pengetahuan pesakit tentang diabetes dan juga 
kepatuhan terhadap pengubatan dan perkaitannya dengan kawalan glisemik. 
Dalam usaha meneroka persepsi, pengetahuan dan pengalaman pesakit tentang 
diabetes, dua belas orang pesakit ditemu bual.  Hasil analisis kandungan tema 
daripada temu bual mengenal pasti empat tema utama: pengetahuan tentang diabetes 
dan pengubatannya, pengalaman kesan berbahaya daripada pengubatan, isu berkaitan 
kepatuhan, dan impak daripada perkaitan perubatan dan keluarga terhadap 
kesejahteraan hidup. Pengalaman kesan berbahaya daripada pengubatan dan 
penyakit, pengetahuan diabetes, perkaitan pesakit-preskriber, sokongan sosial dan 
kepercayaan pesakit dan sikap yang wujud untuk memainkan peranan dalam isu 
kepatuhan pengubatan. 
Ujian Pengetahuan Diabetes Michigan (Michigan Diabetes Knowledge Test, MDKT) 
dan Skala Kepatuhan Pengubatan Morisky (Morisky Medication Adherence Scale, 
MMAS) digunakan untuk menilai pengetahuan diabetes secara umum dan kepatuhan 
terhadap pengubatan. Sampel seramai 307 orang pesakit dipilih daripada klinik 
pesakit luar  diabetes di Hospital Pulau Pinang untuk mengesahkan kedua-dua skala 
ini dari segi versi Malaysia. Suatu  prosedur standard “maju-mundur” digunakan 
untuk menterjemah skala ini ke dalam bahasa Melayu. Kebolehpercayaannya diuji 
bagi ketekalan dalaman dan kesahihannya disahkan  melalui kumpulan yang 
diketahui dan konvergen, MMAS dan MDKT menunjukkan ketekalan dalaman yang 
boleh diterima dan kebolehpercayaan ujian-ujian semula. Bahagian kajian ini 
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merumuskan bahawa kedua-dua MDKT dan  MMAS adalah sahih dan boleh 
dipercayai dan boleh digunakan dalam kalangan pesakit diabetes dalam konteks 
Malaysia. 
Kohort seramai 540 orang pesakit dipilih daripada klinik pesakit luar diabetes di 
Hospital Pulau Pinang bagi penilaian pengetahuan diabetes, kepatuhan pengubatan, 
dan kawalan glisemik. Dapatan kajian menunjukkan bahawa 41.8% dan  42.2% 
daripada pesakit masing-masing mempunyai tahap pengetahuan diabetes dan 
kepatuhan pengubatan yang rendah. Daripada keseluruhan kohort, hanya 20.8% 
pesakit mencapai kawalan glisemik yang baik. Perkaitan yang signifikan ditemui di 
antara tiga pemboleh ubah: HbA1C, pengetahuan diabetes dan kepatuhan terhadap 
pengubatan.  Peramal kawalan glisemik yang baik adalah tahap pengetahuan yang 
tinggi tentang diabetes dan kepatuhan terhadap pengubatan, dan juga terapi mono 
bagi pengurusan  diabetes. 
Justeru, dirumuskan bahawa pengetahuan pesakit tentang diabetes adalah dikaitkan 
dengan kepatuhan terhadap pengubatan dan kawalan glisemik yang lebih baik.  
Sehubungan dengan faktor lain yang menpengaruhi kepatuhan terhadap pengubatan 
dan kawalan glisemik, maka penyedia penjagaan kesihatan sepatutnya memberikan 
tumpuan terhadap tahap pengetahuan pesakit apabila mempertimbangkan kepatuhan 
mereka terhadap pengubatan. Usaha keras diperlukan untuk meningkatkan 
pengetahuan pesakit dan seterusnya kepatuhan terhadap pengubatan dan kawalan 
glisemik. Hasil kajian ini mengutarakan  beberapa cadangan bagi penilaian secara 
berkala tentang pengetahuan pesakit berhubung dengan kepatuhan pengubatan dan 
penggunaan program pendidikan untuk meningkatkan keupayaan pengurusan diri 
pesakit. 
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ASSESSMENT OF KNOWLEDGE AND ADHERENCE TO MEDICATION: 
A MIXED METHODOLOGY STUDY AMONG PATIENTS WITH TYPE-2 
DIABETES MELLITUS IN PENANG 
 
ABSTRACT  
The prevalence of diabetes mellitus had increased tremendously among the 
Malaysian population during the last decade. Furthermore, managing diabetes related 
morbidity is always faced with challenges by the healthcare providers. In order to 
provide optimal disease management, there is a need for diabetic patients to be 
exposed to diabetes self management approach. Although numerous measures have 
been taken to improve glycemic control among patients with diabetes in Malaysia, 
the results are still unfavorable. Adherence to medications, level of knowledge of 
patients’ and the perception they carry about diabetes has not been well documented 
in developing countries. Most interventions attempted to improve medication 
adherence and self-management practices were educational in context. These 
interventions were based on the assumption that knowledge regarding diabetes might 
affect patients’ awareness and influence their adherence to treatment regimen. Within 
this context, limited studies have been conducted in Malaysia focusing on knowledge 
towards diabetes and medication adherence. In addition, experiences and perceptions 
of diabetic patients about the disease and its medications are not highlighted. 
In order to explore and understand patients’ beliefs and experiences, qualitative 
research methods found to be useful. It even enlightens the aspects of research which 
quantitative research alone is unable to uncover, and to explain the complete scenario 
in the research field. Therefore, this cross-sectional mixed methodology (qualitative 
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and quantitative study) principally aimed to evaluate patients’ knowledge about 
diabetes as well as medication adherence and its association with glycemic control. 
In order to explore patients’ perception, knowledge and experience about diabetes, 
twelve patients were interviewed. Thematic content analysis of the interviews 
identified four major themes: knowledge about diabetes and its medication, 
experiences of adverse effects of medication, issues related to adherence, and the 
impact of medical and family relationships on well-being. Experience of adverse 
effects of medication and disease, diabetes knowledge, the patient–prescriber 
relationship, social support and patients' belief and attitudes appeared to play a role 
in the issue of medication adherence.  
The Michigan Diabetes Knowledge Test (MDKT) and the Morisky Medication 
Adherence Scale (MMAS) were used for the assessment of general diabetes 
knowledge and medication adherence respectively. A sample of 307 patients was 
conveniently recruited from the outpatient diabetes clinic at Hospital Pulau Pinang 
for the purpose of validation of Malaysian versions of these two scales. A standard 
“forward-backward” procedure was used to translate the scales into the Malay 
language. Reliability was tested for internal consistency and validity was confirmed 
using convergent and known group validity. MMAS and MDKT showed acceptable 
internal consistency and test-retest reliability. This part of the study concluded that 
both MDKT and MMAS were valid and reliable and can be used among patients 
with diabetes in the Malaysian setting.  
A cohort of 540 patients was conveniently recruited from the outpatient diabetes 
clinic at Hospital Pulau Pinang for the evaluation of diabetes knowledge, medication 
adherence and glycemic control. The study findings revealed that 41.8% and 42.2% 
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of patients respectively had a low level of diabetes knowledge and medication 
adherence. Of the entire cohort, only 20.8% of patients achieved good glycemic 
control. Significant associations were found between the three variables HbA1C, 
diabetes knowledge and medication adherence. Predictors of good glycemic control 
were a higher level of diabetes knowledge, a higher level of medication adherence 
and mono therapy for diabetes management. 
Therefore, it is concluded that patients’ knowledge about diabetes is associated with 
better medication adherence and better glycemic control. In addition to other factors 
affecting medication adherence and glycemic control, healthcare providers should 
pay attention to the level of knowledge held by patients when considering their 
medication adherence. Extra effort is required to improve patients’ knowledge and 
thus medication adherence and glycemic control. The study results reinforce the 
recommendations for the periodic assessment of patients’ knowledge regarding 
medication adherence and the use of educational programs to improve the self-
management ability of patients. 
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 CHAPTER ONE: INTRODUCTION 
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1.1 Background of the study 
In recent decades, the ability to diagnose and treat by the medical professionals has 
greatly grown with an increase in medical knowledge and new technologies. 
However, the effectiveness of this growth is challenged by the requirement of 
patients to change their behavior. All over the world, there have been rapid changes 
in disease prevalence. Diabetes mellitus (DM), along with the other chronic diseases 
such as heart diseases, stroke, cancer, hypertension and mental illnesses, now 
accounts for 47% of the global health burden of disease and 60% of all deaths 
(Fincham, 2007).  
The prevalence of diabetes is increasing continuously. High levels of its morbidity 
and mortality is a mounting health problem in the contemporary era. More than 171 
million people were affected by diabetes worldwide in 2000 and the prevalence of 
this disease is estimated to be 366 million in 2030 (Wild et al., 2004). According to 
Frank Vinicor (the director of the division of diabetes translation at the Centers for 
Disease Control and Prevention in Atlanta) “every 24 hours, 4,100 new diabetes 
cases are diagnosed in the U.S., at least 810 people die, 230 undergo amputation, 120 
learn they need kidney dialysis or transplant, and 55 go blind” cited from (Beckley, 
2006). Type 2 diabetes accounts for about 90% of cases of diabetes and is more 
likely to occur in developing countries due to a sedentary lifestyle, aging, obesity and 
poor dietary habits (World Health Organisation, 2009). Diabetes can affect any 
person of either gender, at any age from any race and socio-economic background, 
but Asians are affected more than Caucasians (International Diabetes Federation, 
2005).  
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Diabetes epidemic is mainly found in Asia. The prevalence of diabetes in this 
racially heterogeneous population with different demographical, cultural and socio-
economic backgrounds has rapidly increased among urban and younger people 
(Chan et al., 2009; Ramachandran et al., 2009; Sicree et al., 2006; Wild et al., 2004; 
Yoon et al., 2006). Countries undergoing substantial economic growth are more 
likely to show an increased prevalence of diabetes, and epidemiological data from 
Asian countries has attracted attention to this problem (Ramachandran et al., 2009).  
The proportion of urbanization in Singapore, Korea, Malaysia, the Philippines and 
Indonesia will be more than 50% by 2010 (Ramachandran et al., 2009). Urban 
lifestyles are associated with changes in the level of physical activity and increased 
diversity of the diet, including animal-based foods along with more unsaturated and 
total fats and a low intake of fiber. Chronic diseases like diabetes are diet-related and 
the effect of poor dietary habits is significant to the etiology of these diseases (Chan 
et al., 2009; Ramachandran et al., 2009).  However, Asian populations tend to 
develop diabetes with a lower degree of obesity and at a younger age, meaning that 
they suffer longer from complications and die sooner than people from other regions 
(Ko et al., 1999; Yoon et al., 2006). 
 
1.2 Diabetes in Malaysia 
Malaysia is a multiethnic country with a total population of 28.25 million 
(Department of Statistics Malaysia, 2010).  According to the Third National Health 
and Morbidity Survey (NHMS-3) in Malaysia, the prevalence of type 2 DM in adults 
aged 30 years and over now stands at 14.9%, increased from 8.3% in 1996, with the 
highest prevalence among those of Indian ethnicity (National Health and Morbidity 
4 
 
Survey III, 2006). The number of people with diabetes is expected to increase from 
1,846,000 in 2010 to 3,254,994 in 2030, and the adjusted prevalence of diabetes 
(adjusted to the world population) in Malaysia will rise from 11.6% in 2010 to 13.8% 
in 2030 (International Diabetes Federation, 2009). In the Malaysian Ministry of 
Health, there is an increasing interest in the increasing prevalence of chronic disease, 
including diabetes, within the population (Lim and Morad, 2004). This increase in 
prevalence of diabetes is associated with many factors, including rapid economic 
growth of the country in the last few decades, urbanization and industrialization 
which have resulted in more overweight/obese people and a sedentary population 
(Ismail et al., 2002; Kee et al., 2008; Mustaffa, 2004; Rashid, 2008).  A jumping 
transformation in socioeconomic and demographic status over the last two decades 
has occurred in Malaysia as a result of massive industrialization and globalization 
with an improved educational system (Yun et al., 2007). As a result, the standard of 
living, quality of life, population and the concomitant ageing of the population and 
reduction in the death rate have improved (Yun et al., 2007). The Malaysian 
population in the age group of 65 years and above has increased from 4.3 % in 2005 
to 4.8 % in 2007 which indicates that the number of Malaysian senior citizens has 
gradually increased over time compared to the younger group (Yahya et al., 2008). 
In this age group, around 25% to 30% of people have diabetes or glucose intolerance 
(Wild et al., 2004).  
 
 
1.3 Diabetes Care in Malaysia 
Diabetes cannot be cured, but can be controlled with combination of medical care, 
patients education and patient self-management (American Diabetes Association, 
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2009; Ministry of Health Malaysia, 2009). Multiple diabetes complications (vascular 
complications) in Malaysian patients with type 2 diabetes have been found to be as 
high as 38% (Dhanjal et al., 2001; Mafauzy, 2006; Mimi et al., 2003; Ooyub et al., 
2004). Out of all the patients who require dialysis in Malaysia, 57% are as a result of 
diabetic nephropathy (Lim and Lim, 2006) and 55% of patients who suffered from 
stroke were patients with diabetes (Hamidon and Raymond, 2003; Wong, 1999). 
Diabetes was the eighth in the list of top ten causes of death by non-communicable 
diseases, and diabetes also was the fifth most important cause of disability in 
adjusted life years (Yusoff et al., 2005). Studies on diabetes in Malaysia reported that 
a large proportion of patients had poor or suboptimal glycemic control and the mean 
HbA1C was higher than the recommended HbA1C level according to international 
guidelines (Chuang et al., 2002; Ismail et al., 2001; Ismail et al., 2000; Kamarul 
Imran et al., 2010; Mafauzy, 2005; Mafauzy, 2006; Mimi et al., 2003; Sulaiman et 
al., 2004; Tan et al., 2008; Wong and Rahimah, 2004; Yusof et al., 2009). 
 
1.4 General diabetes knowledge 
A low level of awareness within the population, among health professionals and a 
low priority to initiate an appropriate preventive and curative plan have been 
identified as major issues in the management of diabetes (Ooyub et al., 2004). A low 
level of diabetes knowledge among patients with diabetes has been identified in other 
countries (Al Shafaee et al., 2008; Angeles-Llerenas et al., 2005; Bell et al., 1997; 
Bruce et al., 2003; Caliskan et al., 2006; Gunay et al., 2006; Habib and Aslam, 2003; 
Kamel et al., 1999; McClean et al., 2001; Murata et al., 2003; Murugesan et al., 
2007; Speight and Bradley, 2001; West and Goldberg, 2002). Diabetes self-
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management is a cornerstone for the proper management of patients with diabetes, 
and diabetes education has a role in improving diabetes outcomes (Funnell et al., 
2007; Simmons et al., 1994). Diabetes self-management education has shown a 
positive effect on glycemic control, lipid and blood pressure control in patients with 
diabetes (Gagliardino and Etchegoyen, 2001; Norris et al., 2001). Knowledge of 
diabetes is a central part in informed decision making on the pharmacological and 
non-pharmacological aspects of diabetes management and evaluation of patients 
needs, and has been recommended to achieve better metabolic control (Al-Adsani et 
al., 2009; Mensing et al., 2007; Murata et al., 2003). However, modest 
improvements in glycemic control have been found after educational intervention 
with diabetes patients (Acik et al., 2004). Improved information from the family 
physician to patients with chronic diseases has also been recommended to improve 
medication adherence (Burge et al., 2005; Karaeren et al., 2009). A well-developed 
educational program is essential for the improvement of medication adherence and 
diabetes outcomes in terms of glycemic control and an evaluation of the educational 
needs for patients is essential as a first step. 
 
1.5 Medication adherence 
Self-management and health behavior changes play central roles in diabetes care. In 
order to achieve optimal health, the diabetes patients are usually advised on 
appropriate diet, exercise, frequent medical examinations (annual eye, foot and 
kidney examinations). They are also usually prescribed multiple medications to be 
taken daily. However, this advice, recommendations and behavior must be 
maintained lifelong. If patients do not properly adhere to these guidelines, their 
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diabetes is more likely to be poorly controlled with an increased risk of developing 
further health problems. Christensen and Johnson stated that “Whether medical 
intervention requires a patient to follow a prescribed medication regimen, involves 
making a necessary dietary or other lifestyle change, or simply requires an 
individual to attend a scheduled appointment or procedure, the patient’s adherence 
is, in virtually all cases, a necessary condition for safe, effective, and efficient 
treatment” (Christensen and Johnson, 2002). The success in ensuring a healthy life 
for patients with diabetes requires a good association between both the health care 
providers who follow the patient’s progress and prescribe the appropriate treatment 
and the patient who has the responsibility for following recommendations and 
maintaining behavioral changes.  
Generally, medication adherence is considered to be the extent to which patients take 
medication as prescribed by the health professional (Eraker et al., 1984; Vitolins et 
al., 2000). One of the most important targets in the management of patients with 
diabetes is the control of blood glucose by proper adherence to medications. Positive 
health outcomes and lower mortality among patients with diabetes have been 
associated with good adherence compared with those patients with poor adherence 
(Krapek et al., 2004; Rhee et al., 2005b; Simpson et al., 2006). Patients with good 
adherence to medications were more able to maintain their glycemic control, had 
lower HbA1c, fewer hospital admissions, an overall reduction in morbidity and 
mortality and lower medication costs (Hepke et al., 2004; Mahoney, 2008; Piette et 
al., 2004b; Schectman et al., 2002). Poor adherence is not only a problem among 
patients with diabetes, but also with other chronic diseases such as hypertension and 
hyperlipidemia (Dunbar-Jacob and Mortimer-Stephens, 2001; Haynes et al., 2002; 
Sabate, 2003).  
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Poor adherence to medications in diabetes found to be a major contributor to poor 
glycemic control (Balkrishnan et al., 2003). Besides, a strong association has been 
found between poor adherence and increased health service utilization (Dalewitz et 
al., 2000). The effectiveness of pharmacological treatment in diseases are mainly 
dependent on the efficacy of the medication and the rate of adherence to the 
medication (Epstein, 1984). Previous behavioral studies in patients with diabetes 
have shown that taking medication can be more easily followed than complying to 
non-pharmacological treatment such as diet and exercise (Gonder-Frederick et al., 
2002). It has been estimated that about 50% of patients were unable to follow their 
pharmacological treatment regimens properly and failed to obtain the full benefit 
from their treatment (Roter et al., 1998).  
The rate of poor or non-adherence appears to be decreasing from high rates for 
preventive regimens in asymptomatic patients to low rates for time-limited regimens 
in acutely ill patients (Horne, 2006). Poor adherence has been linked to an increased 
frequency of illness, treatment failures, hospitalization and to higher mortality across 
many clinical populations (Christensen and Johnson, 2002). Poor medication 
adherence in diabetes has been documented in many research studies and reviews 
have suggested that a large proportion of patients have difficulty in totally adhering 
to their medication. A retrospective analysis review concluded that the adherence 
rate to diabetic medications ranged from 36 to 93% (Cramer, 2004). In a study 
conducted in Scotland, 69% and 66% of patients were poor adherent to 
sulphonylureas and metformin respectively (Donnan et al., 2002). A report by the 
WHO estimated that the average rate of adherence to medication is around 50% 
among patients suffering from chronic diseases in developed countries, and this is 
assumed to be lower in developing countries where there is limited access to health 
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care and medicines (World Health Organization, 2003). It was reported in Nigeria 
that 39.8% of patients with type 2 DM were poor adherent to their medications 
(Adisa et al., 2011).  
 
 
1.6 Research Problems 
Diabetes management is lifelong process that requires efforts from diabetic health 
care providers and patients. However, the patient is the key for successful 
management and serious complications can result from poor management. Patients 
must be proficient to successfully manage, maintain lifestyle changes and make daily 
decisions for their objectives while health care providers have the responsibility to 
help patients to make the right decision and cope with the difficulties and barriers 
through education, support and advice (Funnell and Anderson, 2004).  
This study has illustrated the following problems: 
1- The proportion of good glycemic control constitutes a small percentage 
among the total patients with diabetes in Malaysia.   
2- To date, there have been few academic and empirical published papers 
regarding knowledge and medication adherence and most of the reviews on 
this subject have been conducted in Western countries. 
3- In Malaysia, there has been a shortage of data on the topic of patients’ 
experience and knowledge about diabetes and its medications among patients 
with type 2 diabetes.  
4- No validated Malaysian tools have been found for the assessment of diabetes 
knowledge and medication adherence. 
10 
 
5- Little has been published regarding the association of both knowledge and 
adherence on glycemic control in patients with diabetes. 
6- Inconclusive results have been found in previous studies that investigated the 
association between general diabetes knowledge and medication adherence 
and their impact on glycemic control. 
 
1.7 Rationale of the study 
Diabetes is a growing health problem in Malaysia with a high cost in terms of 
economics and disability. It is estimated that 3,254,994 people will have diabetes in 
2030 in Malaysia compared with the estimate of 1,846,000 in 2010 (International 
Diabetes Federation, 2009). This increase is due to rapid socio-economic growth, 
urbanization and changes in dietary habits resulting in an increase in the proportion 
of the obese and overweight population. The NHMS-3 found that the prevalence of 
diabetes increased from 8.3% in 1996 to 14.9% in 2006 with a high prevalence of 
poor glycemic control. Patients with type 2 diabetes frequently do not adhere to their 
prescribed medications and, consequently, poor glycemic control can result, with an 
increased incidence of diabetic complications, increased morbidity and mortality and 
increased health care facilities utilization (Delamater, 2006; Hertz et al., 2005). 
Multiple factors have been found to be related to medication adherence, such as 
patient variables, health status, medications, economic variables and health care 
provider variables (Balkrishnan et al., 2003). Although numerous measures have 
been taken to improve glycemic control among patients with diabetes in Malaysia, 
there is still a lack of good diabetes control. In Malaysia, it is important to explore 
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the patients’ perception about the diabetes, diabetes medications and the interaction 
between patients and health care providers. It is also imperative to understand the 
contribution of general diabetes knowledge among patients with type 2 diabetes on 
their medication adherence behavior to promote better self-care for diabetes. Lack of 
proper self-management and poor adherence to medications are responsible for the 
high prevalence of poor diabetes control (Ruggiero et al., 1997; Whittemore, 2000). 
It has been recommended that diabetes education should be a component of the 
diabetes management process by the health system (Harris, 1996). Most of the 
interventions that attempt to improve medication adherence and self-management 
practice of patients are educational; therefore, for a proper intervention that leads to 
changes in patient behavior, it is important to first evaluate patient knowledge. 
Diabetes self-management education must be adjusted to the level of knowledge of 
the patients and should be culturally sensitive. 
 
1.8 Significance of the study 
As a result of the rapidly growing prevalence of diabetes and with the evidence that 
good glycemic control of diabetes is associated with reduced morbidity, mortality, 
and disability, diabetes self-management has been considered as an important part of 
the management of patients with diabetes (American Diabetes Association, 2009). 
Medication adherence is an important element of diabetes self-management to 
improve glycemic control and to prevent complications, and a patient’s knowledge of 
diabetes is highly correlated to medication adherence (Okuno et al., 1999). Poor 
medication adherence may result in worsened outcomes and additional medication 
regimens to be added to the prescription. Although many studies regarding 
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medication adherence among patients with diabetes are available, published data on 
medication adherence and the factors contributing to it in Malaysia is sparse.  
It has been recommended by the American Diabetes Association to annually assess 
diabetes self-management skills of patients and to provide continuous diabetes 
education  (American Diabetes Association, 2009). Diabetes knowledge is required 
for proper self-management of diabetes (Browne et al., 2002; Coates and Boore, 
1996; Norris et al., 2001; Speight and Bradley, 2001), However, little is known 
regarding the specific skills, knowledge and beliefs needed for the patients to 
effectively participate in their diabetes management (Heisler et al., 2005). Therefore, 
the assessment of patient knowledge is important for improving patient outcomes 
(Rothman et al., 2005). This study will attempt to discover the association between 
patient knowledge on diabetes and medication adherence. 
Many factors and barriers related to medication adherence are noted from previous 
studies but, in the Malaysian setting, little is known about these factors and how they 
contribute to the problem of poor glycemic control. It is important to determine the 
perception of patients and their experience with diabetes and the associated 
medications for the purpose of evaluating the factors affecting glycemic control. At 
the end of this study, healthcare professionals and authorities will have a clearer 
picture of the problem of medication adherence. The results from this study will help 
to explore patient perceptions of diabetes, identify patients with poor knowledge and 
adherence and identify patients with poor glycemic control. The results will help in 
planning educational programs for patients with diabetes and help health care 
providers to concentrate on those patients with risk factors for poor adherence. 
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1.9      Research objectives and questions 
1.9.1 Objective of the study 
Poor glycemic control of diabetic patients is a major public health problem that 
requires attention. Patients often do not adhere tightly to their prescribed 
medications. It is important to understand the contribution of factors associated with 
poor adherence in order to provide better care. Some interventions which have been 
carried out to improve medication adherence involve an educational program; 
therefore, this study assumed that knowledge regarding Malaysian patients might 
affect their awareness in terms of medication use and could consequently influence 
adherence to a medical regimen. To date, few papers have been published in terms of 
the assessment of both patient knowledge and medication adherence in type 2 
diabetes. Therefore, further exploration of the association between medication 
adherence and patient knowledge and the effect of both of these factors on glycemic 
control is needed. The principal purpose of the study was to investigate the 
medication adherence of patients with diabetes and the general knowledge and the 
association of both knowledge and adherence on glycemic control. The study 
findings may provide the healthcare system with a better understanding of the effect 
of knowledge improvement on medication adherence of patients and consequently on 
glycemic control. 
The specific aims of this study are: 
1- To explore the perception and knowledge of diabetic patients on diabetes and 
thier medications. 
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2- To understand the factors contributing to medication adherence in Malaysian 
patients. 
3-  To translate, validate and assess the psychometric properties of the chosen 
tools for the assessment of general knowledge and medication adherence. 
4- To evaluate general diabetes knowledge and medication adherence among 
patients with type 2 diabetes 
5- To identify the characteristics of the patients who have low level of 
knowledge, low medication adherence and poor glycemic control 
6- To examine the relationship between the general knowledge of patients and 
their medication adherence with glycemic control 
7- To examine the factors affecting the patients to be in a good glycemic 
control. 
1.9.2 Research questions 
The study addressed the following questions:  
1- Is there a high prevalence of poor medication adherence? What is the 
percentage of medication adherence in patients with diabetes? 
2- Is there a general diabetes knowledge deficiency among patients with type 2 
diabetes? 
3-  Do patients with different degrees of diabetes knowledge adhere differently 
to their diabetic medication? 
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4- Which of the two variables (knowledge and adherence), including interaction 
variables, account for the most variance in predicting HbA1C levels? 
5- What is the type and strength of the relationship between patients’ 
characteristics and the other two variables (knowledge and adherence) as well 
as the outcome (HbA1C)? 
1.10    Thesis overview    
In this thesis, chapter 2 reviews the literature related to the study with the definition 
of terms and provides a conceptual framework for the study. A brief discussion of the 
importance of diabetes knowledge and medication adherence for patients is discussed 
in depth. The chapter continues with an overview of diabetes knowledge assessment 
and the tools used for its measurement with an overview of medication adherence 
assessment and the methods used for its measurement. A thorough review of 
literature relevant to the study, focusing on at patient knowledge and medication 
adherence in regards to diabetes and its medications in Malaysia and elsewhere in the 
world form the bulk of this chapter.  
Chapter 3 illustrates the qualitative exploration of patient perceptions and experience 
of diabetes and its medications. A detailed methodology will be presented for the 
assessment of qualitative interviews with conveniently sampled patients with 
diabetes in Penang. The findings from the interviews conducted with patients about 
their perceptions and experience regarding diabetes and its medications with a 
discussion and conclusions are also presented in this chapter.   
Chapter 4 will illustrate the Malaysian translation of the psychometric validation 
scales used for the assessment of both general diabetes knowledge and medication 
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adherence. Detailed methodology, findings and conclusions for the validation of the 
general diabetes knowledge test used in this study is included.  
Chapter 5 illustrates the assessment of general diabetes knowledge and medication 
adherence and glycemic control as well as their impact on glycemic control. The 
detailed methodology, findings and conclusions for the assessment of patient 
knowledge, medication adherence and glycemic control is described.  
Chapter 6, the final chapter, includes an overall summary of the study findings, the 
conclusions of the thesis and along with a set of recommendations for further work. 
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 CHAPTER TWO: LITERATURE REVIEW 
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2.1     Diabetes mellitus 
2.1.1 Definition of diabetes mellitus 
Diabetes mellitus (DM) is a common chronic disease characterized by 
hyperglycemia and other metabolic abnormalities and is mostly due to insulin 
deficiency, insulin resistance and/or increased hepatic production of glucose (in type 
2 diabetes). Diabetes is “a group of metabolic diseases characterized by 
hyperglycemia and resulting from a defect in insulin secretion, insulin action or 
both” (American Diabetes Association, 2005). DM occurs when the body fails to 
absorb glucose due to factors associated with insulin availability or inappropriate 
insulin action. 
 
2.1.2 Types of diabetes    
Genetically, etiologically, and clinically, diabetes is a heterogeneous group of 
disorders (Koda-Kimble et al., 2009). Based on the etiology of diabetes, there are 
three main types of diabetes: type 1, type 2 and gestational diabetes. However, other 
specific types of diabetes also exists such as maturity onset diabetes of the young 
(MODY) in which these forms of diabetes are frequently characterized by onset of 
hyperglycemia at an early age (generally before age 25 years) and are characterized 
by impaired insulin secretion with minimal or no defects in insulin action (American 
Diabetes Association, 2011; The Expert Committee on the Diagnosis Classification 
of Diabetes Mellitus, 2007). Moreover, latent autoimmune diabetes in adults 
(LADA), is a subgroup of type 2 diabetes and the patients share many genetic and 
immunological similarities with type 1 diabetes, suggesting that LADA, like type 1 
diabetes, is an autoimmune disease (Naik et al., 2009). 
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Type 1 diabetes occurs when the insulin-producing cells in pancreas (beta cells) are 
damaged or destroyed by an autoimmune process resulting in a reduced or impeded 
insulin production (Atkinson and Maclaren, 1994; Falorni et al., 1995). The exact 
etiology of type 1 diabetes is not known, but it is believed that a patient’s genetic 
background in the context of a possible infectious trigger leads to the development of 
the disease (Genuth et al., 2003a; Mayfield, 1998). Type 1 diabetes mostly afflicts 
individuals around the time of puberty and is treated by insulin, diet and exercise 
(Franz et al., 2004; Koda-Kimble et al., 2009).  
Type 2 diabetes is the most common type of diabetes, occurring in about 90% of 
diabetic patients. Type 2 diabetes results when the body produces less insulin or 
when the cells of the body become insensitive to insulin (American Diabetes 
Association Website). While the incidence of type 1 diabetes is highest in children 
and around puberty, type 2 diabetes also known as adult onset diabetes (Howlett and 
Lillie, 2006). However, the incidence of type 2 diabetes in children is also increasing 
along with the epidemic of childhood obesity (Ludwig and Ebbeling, 2001; 
Silverstein and Rosenbloom, 2001). Type 2 diabetes has been found to have a strong 
genetic component with a three-fold higher risk among the siblings of an individual 
with diabetes (Elbein, 2002).  
Gestational diabetes, which is the third main type of diabetes, occurs in about 4% of 
pregnant women in the US (Engelgau et al., 1995). Like type 1 diabetes, the exact 
etiology is not well understood, but hormones from the placenta are believed to block 
the action of insulin in the mother’s body (Koda-Kimble et al., 2009). Usually, 
gestational diabetes is temporary and disappears after the end of the pregnancy; 
however, an increased risk of impaired glucose tolerance and type 2 diabetes remains 
and women with gestational diabetes have a 17%-63% risk of developing type 2 
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diabetes within the next 5-16 years (Ben-Haroush et al., 2004; Hanna and Peters, 
2002; Henry and Beischer, 1991).  
The fourth type of diabetes, which is secondary to other conditions, consists of 
diabetes associated with a genetic defect in the function of the beta cells of the 
pancreas, a genetic defect in the action of insulin, diseases of the pancreas, other 
genetic syndromes, drug use or chemical exposure (Diabetes Mellitus Information, 
2006).  
The assessment and discussion in this study is limited to type 2 DM and the term 
diabetes that subsequently appears in this study refers to type 2 DM. 
 
2.1.3 Diagnosis of diabetes 
Diabetes is usually diagnosed when one or more of the usual signs and symptoms of 
diabetes are present and confirmed by a high level of glucose in a venous blood 
sample. The recommended criteria for the diagnosis of DM are as follows (American 
Diabetes Association, 2009; International Diabetes Federation, 2005; Ministry of 
Health Malaysia, 2009; Rodbard et al., 2007).  
1- When there are symptoms of diabetes (polyuria, polydipsia and weight loss) 
associated with causal (any time of day, with no regard to the last meal) fasting 
blood sugar (FBS) more than 11.1 mmol/L 
2- FBS is equal to or more than 7 mmol/L 
3- Two hour postprandial plasma glucose is equal to or more than 11.1mmol/L. 
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2.1.4 Clinical presentation of type 2 diabetes  
Type 2 diabetes is typically diagnosed incidentally during a routine physical 
examination or when the patient seeks attention for another complaint. This is 
because symptoms are so mild and their onset so gradual that they can easily be 
explained away (Koda-Kimble et al., 2009). However, when the patients giving a 
history of their illness, fatigue, polyuria, and polydipsia are acknowledged (Alberti 
and Zimmet, 1998; Boron and Boulpaep, 2003; Ganong and Systems, 1995; Koda-
Kimble et al., 2009). Weight loss is uncommon, and macrovascular disease is also 
often evident at diagnosis while the presence of microvascular complications at 
diagnosis suggests the presence of undiagnosed or subclinical diabetes for 7 to 10 
years (Koda-Kimble et al., 2009).  
 
2.1.5 Glycosylated hemoglobin A1C (HbA1C) 
HbA1C is a result of the reaction between glucose and hemoglobin in the blood. The 
hemoglobin is exposed to glucose in the blood and when there is a higher level of 
glucose, more HbA1C will be formed. HbA1C is an important marker and is an 
index for glycemic control. HbA1C is considered as the gold standard for the 
evaluation of diabetes control as it provides an average blood glucose over the 
preceding two to three months (American Diabetes Association, 2009; Katsilambros 
and Tentolouris, 2003). The normal level of HbA1C in a non-diabetic person ranges 
from 3.8-6.4% of the total hemoglobin (Goldstein et al., 2004; Kasper et al., 2005). 
According to the 2009 American Diabetes Association recommendations, a HbA1C 
less than 7% is desired for good glycemic control (American Diabetes Association, 
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2009), while a HbA1C equal to or less than 6.5% was recommended by the 
American Association of Clinical Endocrinologists (Rodbard et al., 2007).  
The target level of equal or less than 6.5% HbA1C for patients with type 2 diabetes is 
recommended by the Malaysian Clinical Practice Guidelines for the management of 
type 2 diabetes (Ministry of Health Malaysia, 2009). There is strong evidence that 
HbA1C should be measured routinely in all patients with diabetes (type 1 and 2) in 
order to evaluate the degree of glycemic control. Glycemic goal should be based on 
the results of prospective randomized clinical trials like the Diabetes Control and 
Complications Trial (DCCT), the United Kingdom Prospective Diabetes Study 
(UKPDS) and Action in Diabetes and Vascular disease: preterAx and diamicroN 
Controlled Evaluation (ADVANCE) or based on the guidelines for the management 
of diabetes (Sacks et al., 2002). 
 
2.1.6 Diabetes complications 
There are different forms and types of complications associated with diabetes which 
vary from acute to chronic in onset and can be classified by the type of tissues or 
cells where complications occur (Fowler, 2008). Generally, complications are more 
common in patients who have difficulty in controlling their blood glucose at 
acceptable levels (Stratton et al., 2000).  
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2.1.6.1 Acute complications of diabetes 
Primary or secondary hypoglycemia is an acute complication of diabetes, which can 
be severe and sometimes have rapid consequences and multiple causes, depending on 
the etiology and especially the presence or absence of hyperinsulinemia (Bibergeil, 
1988). Diabetic ketoacidosis also is an acute metabolic complication of diabetes 
resulting primarily from intense insulin deficiency that mostly occurs with type 1 
diabetes and occasionally in type 2 diabetes and which is associated with a mortality 
rate of 10%  (Walker et al., 1989). Hyperosmolar non-ketogenic coma results from 
profound dehydration as a result of fluid loss (pneumonia, burns, stroke or a recent 
operation) or inadequate fluid intake. It is associated with a greater than 50% 
mortality rate and is considered a true medical emergency (Walker et al., 1989). 
2.1.6.2 Chronic complications of diabetes 
The long term complications associated with diabetes can develop in patients with 
type 2 diabetes which include micro and macro-vascular complications. Macro-
vascular complications are responsible for stenosis at the three major arteries which 
are the coronary, cranial and limb arteries (Nesto, 1988; Pyorala and Laakso, 1983). 
Micro-vascular complications of diabetes affect the small blood vessels and 
capillaries resulting in thickening of the basement membrane of the capillaries 
throughout the body. Among the problems caused by this complications are 
retinopathy, nephropathy and neuropathy (Cheung and Wong, 2008; King and 
Brownlee, 1996). Diabetic neuropathy is classified into different types of diabetes 
complications, in which patients suffer from numbness or irritation at the tips of the 
limbs with wasting of manual muscles and impaired reflexes. Neuropathy is the most 
common complication and occurs in 12% of patients at the time of diagnosis and in 
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25% of patients after 25 years of diabetes (Vinik et al., 2000). Other chronic 
complications of diabetes includes autonomic neuropathy, diabetic foot disorder, 
carpal tunnel syndrome, increased susceptibility to infection, poor circulation and 
poor renal function (Herfindal and Gourley, 2000). 
 
2.1.7 Diabetes management  
Diabetes management normally follows the clinical diagnosis with lifestyle 
modification, pharmacotherapy and patient education to encourage self-care and to 
achieve glycemic control (Funnell et al., 2009; Funnell et al., 2007; Martin et al., 
2005). This involves, in addition to the primary medical evaluation of patients, a 
variety of strategies to provide adequate education to the patients and considers 
diabetes self-management education as an integral part of diabetes management with 
dietary planning, pharmacotherapy and exercise (American Diabetes Association, 
2009; Rodbard et al., 2007). For proper implementation of self-management in 
therapeutic plans, a combination of behavioral strategies to improve self-
management requires a multidisciplinary team effort from physicians, pharmacists 
and nurses (American Diabetes Association, 2009). Teaching self-management is 
time consuming and requires repeated contact with health care professionals for 
education, self-monitoring and the assessment of progress. The approach to patients 
should be individualized, taking into consideration their culture, economic situation, 
knowledge and beliefs regarding the disease and treatment, response to medication 
and changes in status over time. 
The aim of adequate diabetes management is to reduce the acute and chronic 
complications of diabetes, principally by maintaining good glycemic control and 
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controlling the other associated risk factors (hypertension and hyperlipidemia) as 
much as possible. Diabetes requires lifelong management, which is challenging and 
sometimes overwhelming for patients who have to manage their diabetes alone or 
with additional support from family members.  
Patients are required to properly adhere to their daily medication intake and to their 
new lifelong lifestyle modifications. Patients need to adhere to their medication, meal 
plans, adjust their physical activity, lose weight if they are obese and monitor their 
blood glucose. For these required activities, patients must acquire knowledge and 
skills through systematic diabetes education. Traditional diabetes education focused 
on the transfer of information from health care professionals to patients, which 
generally does not improve patient behavior or outcomes (Brown, 1992). In order for 
effective education to be achieved, health professionals need to change their 
approach to improve all aspects of self-care behavior, including medication 
adherence and daily self-care. The plan for continuous diabetes management consists 
of three arms, which are relief of the acute symptoms of diabetes, optimized 
glycemic control and mitigation of other risk factors for complications and the 
treatment of the existing complications (Ministry of Health Malaysia, 2009). The 
available choices for the treatment of diabetes are education, diet, pharmacotherapy 
and exercise. 
 
2.1.7.1 Diabetes education 
Diabetes education is effective for improved clinical outcomes and quality of life and 
should be provided to all patients with type 2 diabetes regardless of the mode of 
treatment (Ellis et al., 2004; Gary et al., 2003; Norris et al., 2002). It is important to 
